Literature DB >> 9330968

The natural history of Alzheimer neurofibrillary tangles and amyloid deposits.

B T Hyman1, T Gomez-Isla.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9330968     DOI： 10.1016/s0197-4580(97)00054-7

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN： 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  9 in total

Review 1.  Platelets and Alzheimer's disease: Potential of APP as a biomarker.

Authors:  Geneviève Evin; Qiao-Xin Li
Journal:  World J Psychiatry       Date:  2012-12-22

2.  A limited role for microglia in antibody mediated plaque clearance in APP mice.

Authors:  Monica Garcia-Alloza; Brian J Ferrara; Sarah A Dodwell; Gregory A Hickey; Bradley T Hyman; Brian J Bacskai
Journal:  Neurobiol Dis       Date:  2007-07-28       Impact factor: 5.996

3.  Antioxidants have a rapid and long-lasting effect on neuritic abnormalities in APP:PS1 mice.

Authors:  Monica Garcia-Alloza; Laura A Borrelli; Bradley T Hyman; Brian J Bacskai
Journal:  Neurobiol Aging       Date:  2009-01-04       Impact factor: 4.673

4.  Early Alzheimer-type lesions in cognitively normal subjects.

Authors:  Stergios Tsartsalis; Aikaterini Xekardaki; Patrick R Hof; Enikö Kövari; Constantin Bouras
Journal:  Neurobiol Aging       Date:  2017-10-13       Impact factor: 4.673

5.  Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

Authors:  Aysha S Mohamed Lafirdeen; Emmanuel Cognat; Severine Sabia; Claire Hourregue; Matthieu Lilamand; Aline Dugravot; Elodie Bouaziz-Amar; Jean-Louis Laplanche; Jacques Hugon; Archana Singh-Manoux; Claire Paquet; Julien Dumurgier
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

Review 6.  Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Authors:  José J Jarero-Basulto; Martha C Rivera-Cervantes; Deisy Gasca-Martínez; Francisco García-Sierra; Yadira Gasca-Martínez; Carlos Beas-Zárate
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-26

7.  Existing plaques and neuritic abnormalities in APP:PS1 mice are not affected by administration of the gamma-secretase inhibitor LY-411575.

Authors:  Monica Garcia-Alloza; Meenakshi Subramanian; Diana Thyssen; Laura A Borrelli; Abdul Fauq; Pritam Das; Todd E Golde; Bradley T Hyman; Brian J Bacskai
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

8.  Predicting the location of entorhinal cortex from MRI.

Authors:  Bruce Fischl; Allison A Stevens; Niranjini Rajendran; B T Thomas Yeo; Douglas N Greve; Koen Van Leemput; Jonathan R Polimeni; Sita Kakunoori; Randy L Buckner; Jennifer Pacheco; David H Salat; Jennifer Melcher; Matthew P Frosch; Bradley T Hyman; P Ellen Grant; Bruce R Rosen; André J W van der Kouwe; Graham C Wiggins; Lawrence L Wald; Jean C Augustinack
Journal:  Neuroimage       Date:  2009-04-16       Impact factor: 6.556

Review 9.  Chronic traumatic encephalopathy neuropathology might not be inexorably progressive or unique to repetitive neurotrauma.

Authors:  Grant L Iverson; Andrew J Gardner; Sandy R Shultz; Gary S Solomon; Paul McCrory; Ross Zafonte; George Perry; Lili-Naz Hazrati; C Dirk Keene; Rudolph J Castellani
Journal:  Brain       Date:  2019-12-01       Impact factor: 13.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.